Recent findings in transgenic mice injected with patient‐derived tau seeds or AD brain homogenates suggest that Aβ plaques may be “niches” facilitating the amplification of proteopathic tau seeds and their initial aggregation in neuritic plaques.20, 21. The gene discussed is MAPT; the disease is Alzheimer disease.